Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. American Heart Journal. 2011; 162(6):966-972.e10 95. Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB et al. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program. Journal of the American College of Cardiology. 2007; 50(20):1959-66 96. DeWalt DA, Malone RM, Bryant ME, Kosnar MC, Corr KE, Rothman RL et al. A heart failure self-management program for patients of all literacy levels: a randomized, controlled trial 97. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. New England Journal of Medicine. 1997; 336(8):525-33 98. Doenst T, Cleland JG, Rouleau JL, She L, Wos S, Ohman EM et al. Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease. Circulation: Heart Failure. 2013; 6(3):443-50 Chronic Heart Failure Reference list NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 99. Domanski M, Coady S, Fleg J, Tian X, Sachdev V. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and 100. Domingues FB, Clausell N, Aliti GB, Dominguez DR, Rabelo ER. Education and telephone monitoring by nurses of patients with heart failure: randomized clinical trial. Arquivos Brasileiros de Cardiologia. 2011; 96(3):233-9 101. Dong SJ, de las FL, Brown AL, Waggoner AD, Ewald GA, Davila RV. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort. Journal of the American Society of 102. Doos L, Bradley E, Rushton CA, Satchithananda D, Davies SJ, Kadam UT. 